Datroway
FDA Grants Accelerated Approval to Datroway for Some Patients With EGFR-Mutated NSCLC
The FDA granted accelerated approval to Datroway for some adults with locally advanced or metastatic EGFR-mutated ...
JUNE 25, 2025
FDA Approves Datroway for Unresectable or Metastatic, HR-positive, HER2-negative Breast Cancer
The FDA has approved Datroway, a Trop-2−directed antibody and topoisomerase inhibitor conjugate, for adult ...
JANUARY 22, 2025
Load more